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An IMP-4-producing Acinetobacter pittii strain coproducing oxacillinases was isolated from a leg wound of a 67-year-old female
patient. Identification to the species level by rpoB and gyrB sequencing andmultiplex-PCR-based analysis revealed that the iso-
late was A. pittii. Whole-genome sequencing of this A. pittii isolate determined the presence of blaOXA-96, blaCARB-2, and a novel
blaOXA-421 gene. The position of this novel blaOXA-421 gene was similar to that of blaOXA-51 in A. baumannii, downstream of the
phosphinothricinN-acetyltransferase gene and upstream of fxsA in the chromosome. This A. pittii isolate was found to belong
to sequence type 119 (ST119). Here, we report the first isolation of IMP-4-producing A. pittii ST119 with a novel blaOXA-421 gene
from a patient in Australia and characterize its draft genome.
CASE REPORT
A67-year-old diabetic woman suffered a fall leading to a dis-placed distal spiral tibial plateau fracture. In the weeks prior
to the fall, she had receivedmultiple antimicrobials (clindamycin,
lincomycin, cephalexin, ciprofloxacin, and ceftazidime) for an in-
fected hematoma of the breast and a series of lower respiratory
tract infections. The patient underwent definitive repair of the
fracture but postoperatively developed osteomyelitis. Debride-
ment of the leg wound was performed. Acinetobacter species and
vancomycin-resistant Enterococcus strains were isolated from the
tissue removed. ThisAcinetobacter species (CR12-42) was carbap-
enem resistant. Despite ongoing antibiotic treatment, the pa-
tient’s leg required amputation in March 2013, after continuous
inflammation, infections for more than 5months, and an episode
of severeClostridium difficile infection resulting in colectomy. The
leg infection was resolved by the amputation.
The initial identification of this Acinetobacter species was done
by Vitek 2. Antimicrobial susceptibility testing by Vitek 2
(bioMérieux) showed resistance to carbapenems, ceftazidime,
ceftriaxone, cefepime, gentamicin, tobramycin, trimethoprim-
sulfamethoxazole, ticarcillin-clavulanic acid, and ciprofloxacin
according to the EUCAST standard (1). The isolate was referred to
our laboratory at theUniversity of QueenslandCentre for Clinical
Research. The Acinetobacter isolate was identified to the species
level by a gyrB multiplex PCR, which revealed that CR12-42 was
Acinetobacter pittii (2). Partial rpoB sequencing (3) confirmed that
CR12-42 was A. pittii.
Phenotypic characterization to determine the class of carbap-
enemase was performed as previously described (4–6). The A.
pittii isolate showed ametallo--lactamase phenotype by produc-
ing a larger inhibition zone around carbapenem disks with EDTA
than around carbapenem disks alone (5-mm breakpoint in-
crease in the size of the inhibition zone). The isolate also produced
a positive result in the modified Hodge and Carba NP tests for
carbapenemase production. MICs were determined with Etest
(bioMérieux). The isolate was resistant to all of the carbapenems
tested, i.e., ceftazidime, cefotaxime, cefepime, cefoxitin, ticarcil-
lin-clavulanic acid, trimethoprim-sulfamethoxazole, and cipro-
floxacin (Table 1). Interestingly, this A. pittii isolate was suscepti-
ble to tetracycline,minocycline, colistin, and tigecycline (Table 1).
Carbapenem resistance in Acinetobacter species is commonly
associated with the presence of carbapenem-hydrolyzing class D
-lactamase- or oxacillinase-encoding genes such as blaOXA-23 and
blaOXA-51 in Acinetobacter baumannii (7, 8). A PCR assay and se-
quencing for all of the blaOXA genes frequently present in Acineto-
bacter species, i.e., blaOXA-23-like, blaOXA-51-like, blaOXA-40-like, and
blaOXA-58-like, were performed (7–9). The isolate was positive for
the blaOXA-58-like subclass and negative for other subclasses of
blaOXA. A PCR assay for ISAba1, the common insertion element in
A. baumannii, was also negative. A PCR assay and sequencing for
other carbapenemase-encoding genes (10, 11), i.e., blaIMP,
blaNDM, blaKPC, and blaVIM, were positive for blaIMP-4. A prepared
pair-ended library of the whole genomic DNA was sequenced via
IlluminaMiSeq to further characterize the resistancemechanisms
of A. pittii CR12-42 and to analyze its genome.
Whole-genome DNA sequencing produced a total of
138,932,382 paired-end reads with 30 average coverage. We
used the CLC genomic workbench version 7.5 (CLC Bio, Aarhus,
Denmark) for de novo assembly with a 500-bp minimum thresh-
old resulting in 127 contigs. The draft genome consisted of
4,372,178 nucleotides and was annotated by rapid annotations
using subsystems technology (RAST) (12). RAST annotation
showed that Acinetobacter calcoaceticus PHEA-2 (score, 503) and
Acinetobacter sp. strain SH024 (score, 436) are the two closest
neighbors ofA. pittiiCR12-42. Our isolate was related to only one
otherA. pittii strain, TG6411, but with a lower score of 221. A total
of 13A. pittii draft genomes have been described in the BioProject
(http://www.ncbi.nlm.nih.gov/bioproject/); however, draft ge-
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nomes of only three isolates were published, including one draft
genome of an NDM-1-producing A. pittii strain from China (13).
In silico identification of CR12-42 to the species level by using
rpoB and gyrB showed it to be 100% identical to A. pittii. A. pittii
belongs, together with Acinetobacter nosocomialis, within the A.
calcoaceticus-baumannii complex and was formerly named Acin-
etobacter genomic species 3 (14). In silico analysis of A. baumannii
multilocus sequence typing (MLST) by the Pasteur scheme
(http://www.pasteur. fr/recherche/genopole/PF8/mlst
/Abaumannii.html) identified A. pittii CR12-42 as being of se-
quence type 119 (ST119). The alleles found were cpn-60 (n 36),
fusA (n  20), gltA (n  38), pyrG (n  16), recA (n  38), rplB
(n 18), and rpoB (n 20). It has been reported thatMLSTby the
Pasteur scheme is capable of providing the ST ofA. pittii (15). The
clinical significance ofA. pittii ST119 is indicated by the fact that it
has been reported to be the predominant clone among theA. pittii
strains (18 out of 25) isolated in four hospitals in Japan (16).
Interestingly, these Japanese A. pittii isolates possessed a different
blaIMP variant, blaIMP-19 (16). Of note,A. pittii ST119 has not been
reported previously in Australia.
The resistance genes were screened with ResFinder (17). The
-lactamase-encoding genes blaIMP-4, blaOXA-96, and blaCARB-2
were identified. blaOXA-96 has a single nucleotide difference (a gua-
nine-for-adenine substitution at position 483) from blaOXA-58.
blaOXA-96 had been reported within an A. baumannii isolate from
Singapore that also harbored blaOXA-23 and blaOXA-64 (18). In our
isolate, blaOXA-96 had a genetic context similar to that of blaOXA-58,
which was bracketed by ISAba3 (GenBank accession number
JX968506) (Fig. 1).
In addition, a novel blaOXA gene, blaOXA-421, was identified
(Fig. 1). This gene had a genetic environment identical to that of
the chromosomal blaOXA-51 gene in A. baumannii (19), which in-
cludes two genes that are usually present upstream and down-
stream of blaOXA-51 in A. baumannii, the phosphinothricin N-
acetyltransferase-encoding gene and fxsA, respectively. blaOXA-421
has 95% identity with the previously reported blaOXA gene
(GenBank accession numberCP002177, locus tag BDGL_000903)
from the genome of A. calcoaceticus PHEA-2 (20), which is the
closest neighbor of our CR12-42 isolate, as previously mentioned.
The second closest relative of blaOXA-421 was blaOXA ofAcinetobac-
ter oleivorans, with 89% similarity (GenBank accession number
CP002080, locus tag AOLE_1170) (21). The other blaOXA genes
similar to blaOXA-421 were blaOXA-324, blaOXA-325, blaOXA-326,
blaOXA-332, and blaOXA-354 (88 to 89% similarity), which were re-
cently identified in A. calcoaceticus (22). The carbapenemase ac-
tivity of OXA-421 warrants further investigation.
The blaIMP-4 gene inA. pittiiCR12-42 was located inside a class
1 integron. Downstream from blaIMP-4 were qacG2 and the amino-
glycoside and chloramphenicol resistance genes aacA4 and catB2
(Fig. 1). This genetic context of blaIMP-4 in CR12-42 was found to
be identical to that in an IMP-4-producing A. baumannii strain
from Singapore (GenBank accession number DQ532122) (18).
TABLE 1MICs of antimicrobials for A. pittii CR12-42 as determined by
Etest
Antimicrobial(s) MIC (mg/liter) Interpretationa
Ertapenem 32 Resistant
Imipenem 24 Resistant
Meropenem 12 Resistant
Doripenem 32 Resistant
Cefepime 64 Resistant
Ceftazidime 256 Resistant
Cefotaxime 32 Resistant
Ceftriaxone 32 Resistant
Cefuroxime 256 Resistant
Cefoxitin 256 Resistant
Piperacillin-tazobactam 12 Resistant
Ampicillin-sulbactam 2 Susceptibleb
Ticarcillin-clavulanic acid 256 Resistant
Piperacillin 256 Resistant
Amikacin 12 Intermediate
Gentamicin 256 Resistant
Netilmicin 24 Resistant
Ciprofloxacin 3 Resistant
Tetracycline 0.75 Susceptibleb
Minocycline 0.023 Susceptibleb
Trimethoprim-sulfamethoxazole 32 Resistant
Colistin 0.094 Susceptible
Tigecycline 0.094 Susceptible
a Unless noted otherwise, MIC interpretations are based on EUCAST criteria (1).
b Ampicillin-sulbactam, tetracycline, and minocycline MIC interpretations are based on
CLSI criteria (33).
FIG 1 Genetic contexts of the four -lactamase-encoding genes in A. pittii CR12-42.
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blaIMP-4 has also been reported inAcinetobacter junii fromAustra-
lia; however, the genetic context was not characterized (23). Our
genetic context was also similar to that of blaIMP-4 in the IncHI2-
type plasmid fromEnterobacter cloacae andEscherichia coli and the
IncL/Mplasmid carrying blaIMP-4 in an E. cloacae strain fromAus-
tralia (24, 25). However, the plasmid backbone of these sequences
could not be identified within our draft genome. Further investi-
gation is needed to determine if blaIMP-4 is located on a plasmid or
the chromosome of CR12-42.
A carbenicillinase gene, blaCARB-2 was identified with Res-
Finder. blaCARB-2, which was also designated blaPSE-1, was first
reported in Pseudomonas aeruginosa (26). The genetic context of
blaCARB-2 in CR12-42 was also potentially a class 1 integron with a
truncated integrase (intI1) located upstream of blaCARB-2 (Fig. 1).
Other resistance genes found in this strain included sul1 (sulfon-
amide resistance),msr(E) andmph(E) (macrolide resistance), and
aac-3-IId (aminoglycoside resistance). Consistent with this, theA.
pittii strain was resistant to gentamicin and tobramycin but sus-
ceptible to amikacin. Of note, no 16S rRNAmethylase was found
in this isolate.
Regardless of its resistance to multiple antimicrobials, A. pittii
CR12-42 remained susceptible to tetracycline and minocycline,
which was consistent with the absence of a tetracycline resistance
gene within the draft genome. In addition, theMIC of ampicillin-
sulbactam remained low (2mg/liter), despite the presence ofmul-
tiple carbapenemase-encoding genes. Further, sulbactam is
known to have activity against A. baumannii (27). In a study by
Higgins et al., the ampicillin-sulbactamMIC50 of 115 A. bauman-
nii strains was 2mg/liter (27). Ampicillin-sulbactam susceptibility
was also shown in the majority of the previously reported A. pittii
ST119 strains harboring blaIMP-19 (94%) in Japan (16). In addi-
tion, 94% of these were susceptible to minocycline, similar to the
antimicrobial phenotype of CR12-42 (16). Apart from the differ-
ence in blaIMP variants, CR12-42 has an antimicrobial phenotype
and genotype identical to those of A. pittii ST119 from Japan.
IMP-producing Enterobacteriaceae strains have been fre-
quently reported in Australia. Although OXA-23-like is the main
subclass of carbapenemases identified in A. baumannii, IMP-4 is
occasionally identified in A. pittii in locations such as Hong Kong
and Singapore (18, 28). Other variants of blaIMP, such as blaIMP-1,
blaIMP-8, blaIMP-11, and blaIMP-19, have been described inA. pittii in
Southeast Asia (16, 29, 30).A. pittii has also recently been reported
to produce NDM (31, 32).
Generally,A. baumannii is considered themost important and
the most prevalent Acinetobacter species causing infections. How-
ever,A. pittii has caused hospital outbreaks in TheNetherland and
China (32, 33) and was reported as themost commonAcinetobac-
ter species causing nosocomial infections in Germany (34). Our
study illustrates the emergence of a multidrug-resistant A. pittii
strain inAustralia. Therefore, accurate identification to the species
level and characterization of the prevalence of A. pittii among the
Acinetobacter species isolated in our region and its antibiotic re-
sistance warrant further investigation.
This work was approved by the Royal Brisbane and Women’s
Hospital Human Research Ethics Committee (HREC/13/QRBW/
391: epidemiology, clinical significance, treatment, and outcome
of infections by carbapenem-resistant Enterobacteriaceae and
Acinetobacter species in Queensland). This project is registered as
BioProject PRJNA255268 and BioSample SAMN03003652.
Nucleotide sequence accession numbers. The GenBank ac-
cession number of blaOXA-421 is KM401566. The GenBank acces-
sion number of the draft genome of A. pittii CR12-42 is
JQNT00000000.
ACKNOWLEDGMENTS
We thank themicrobiology staff at the Gold Coast Hospital microbiology
laboratory for the study isolate.
We thank the Pathology Queensland—Study, Education, and Re-
search Trust Fund (4177).W.K. has received a research high degree schol-
arship from Siriraj Hospital, Mahidol University, Bangkok, Thailand.
REFERENCES
1. EUCAST. 2013. Breakpoint tables for interpretation of MICs and zone
diameters. EUCAST, Basel, Switzerland. http://www.eucast.org/clinical
_breakpoints/. Accessed 1 May.
2. Higgins PG, Lehmann M, Wisplinghoff H, Seifert H. 2010. gyrB mul-
tiplex PCR to differentiate between Acinetobacter calcoaceticus and
Acinetobacter genomic species 3. J ClinMicrobiol 48:4592–4594. http://dx
.doi.org/10.1128/JCM.01765-10.
3. Gundi VA, Dijkshoorn L, Burignat S, Raoult D, La Scola B. 2009.
Validation of partial rpoB gene sequence analysis for the identification of
clinically important and emerging Acinetobacter species. Microbiology
155:2333–2341. http://dx.doi.org/10.1099/mic.0.026054-0.
4. Doi Y, Potoski BA, Adams-Haduch JM, Sidjabat HE, Pasculle AW,
Paterson DL. 2008. Simple disk-based method for detection of Klebsiella
pneumoniae carbapenemase-type beta-lactamase by use of a boronic acid
compound. J Clin Microbiol 46:4083–4086. http://dx.doi.org/10.1128
/JCM.01408-08.
5. Dortet L, Poirel L, Nordmann P. 2012. Rapid identification of carba-
penemase types in Enterobacteriaceae and Pseudomonas spp. by using a
biochemical test. Antimicrob Agents Chemother 56:6437–6440. http://dx
.doi.org/10.1128/AAC.01395-12.
6. Picão RC, Andrade SS, Nicoletti AG, Campana EH, Moraes GC,
Mendes RE, Gales AC. 2008. Metallo-beta-lactamase detection: compar-
ative evaluation of double-disk synergy versus combined disk tests for
IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol
46:2028–2037. http://dx.doi.org/10.1128/JCM.00818-07.
7. Higgins PG, Perez-Llarena FJ, Zander E, Fernandez A, Bou G, Seifert H.
2013. OXA-235, a novel class D beta-lactamase involved in resistance to
carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother
57:2121–2126. http://dx.doi.org/10.1128/AAC.02413-12.
8. Runnegar N, Sidjabat H, Goh HM, Nimmo GR, Schembri MA, Pater-
son DL. 2010. Molecular epidemiology of multidrug-resistant Acineto-
bacter baumannii in a single institution over a 10-year period. J Clin Mi-
crobiol 48:4051–4056. http://dx.doi.org/10.1128/JCM.01208-10.
9. Yang HY, Lee HJ, Suh JT, Lee KM. 2009. Outbreaks of imipenem
resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in
a tertiary care hospital in Korea. Yonsei Med J 50:764–770. http://dx.doi
.org/10.3349/ymj.2009.50.6.764.
10. Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for
detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis
70:119–123. http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.002.
11. Sidjabat H, Nimmo GR, Walsh TR, Binotto E, Htin A, Hayashi Y, Li J,
Nation RL, George N, Paterson DL. 2011. Carbapenem resistance in
Klebsiella pneumoniae due to theNewDelhimetallo-beta-lactamase. Clin
Infect Dis 52:481–484. http://dx.doi.org/10.1093/cid/ciq178.
12. Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T, Edwards
RA, Gerdes S, Parrello B, Shukla M, Vonstein V, Wattam AR, Xia F,
Stevens R. 2014. The SEED and the rapid annotation of microbial ge-
nomes using subsystems technology (RAST). Nucleic Acids Res 42:D206–
D214. http://dx.doi.org/10.1093/nar/gkt1226.
13. Chen Y, Cui Y, Pu F, Jiang G, Zhao X, Yuan Y, Zhao W, Li D, Liu H,
Li Y, Liang T, Xu L, Wang Y, Song Q, Yang J, Liang L, Yang R, Han L,
Song Y. 2012. Draft genome sequence of anAcinetobacter genomic species
3 strain harboring a bla(NDM-1) gene. J Bacteriol 194:204–205. http://dx
.doi.org/10.1128/JB.06202-11.
14. Nemec A, Krizova L, Maixnerova M, van der Reijden TJ, Deschaght P,
Case Report
February 2015 Volume 53 Number 2 jcm.asm.org 729Journal of Clinical Microbiology
 o
n
 M
ay 11, 2015 by UQ Library
http://jcm.asm.org/
D
ow
nloaded from
 
Passet V, Vaneechoutte M, Brisse S, Dijkshoorn L. 2011. Genotypic and
phenotypic characterization of the Acinetobacter calcoaceticus-
Acinetobacter baumannii complex with the proposal of Acinetobacter
pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acineto-
bacter nosocomialis sp. nov. (formerly Acinetobacter genomic species
13TU). Res Microbiol 162:393–404. http://dx.doi.org/10.1016/j.resmic
.2011.02.006.
15. Wang X, Chen T, Yu R, Lu X, Zong Z. 2013. Acinetobacter pittii and
Acinetobacter nosocomialis among clinical isolates of the Acinetobacter
calcoaceticus-baumannii complex in Sichuan, China. Diagn Microbiol
Infect Dis 76:392–395. http://dx.doi.org/10.1016/j.diagmicrobio.2013.03
.020.
16. Yamamoto M, Nagao M, Matsumura Y, Hotta G, Matsushima A, Ito Y,
Takakura S, Ichiyama S. 2013. Regional dissemination of Acinetobacter
species harbouringmetallo-beta-lactamase genes in Japan. ClinMicrobiol
Infect 19:729–736. http://dx.doi.org/10.1111/1469-0691.12013.
17. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund
O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimi-
crobial resistance genes. J Antimicrob Chemother 67:2640–2644. http:
//dx.doi.org/10.1093/jac/dks261.
18. Koh TH, Sng LH, Wang GC, Hsu LY, Zhao Y. 2007. IMP-4 and OXA
beta-lactamases in Acinetobacter baumannii from Singapore. J Antimi-
crob Chemother 59:627–632. http://dx.doi.org/10.1093/jac/dkl544.
19. Chen TL, Lee YT, Kuo SC, Hsueh PR, Chang FY, Siu LK, Ko WC, Fung
CP. 2010. Emergence and distribution of plasmids bearing the blaOXA-51-
like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter
baumannii isolates in Taiwan. Antimicrob Agents Chemother 54:4575–
4581. http://dx.doi.org/10.1128/AAC.00764-10.
20. Yu H, Peng Z, Zhan Y, Wang J, Yan Y, Chen M, Lu W, Ping S, Zhang
W, Zhao Z, Li S, Takeo M, Lin M. 2011. Novel regulator MphX represses
activation of phenol hydroxylase genes caused by a XylR/DmpR-type reg-
ulator MphR in Acinetobacter calcoaceticus. PLoS One 6:e17350. http:
//dx.doi.org/10.1371/journal.pone.0017350.
21. Jung J, Madsen EL, Jeon CO, Park W. 2011. Comparative genomic
analysis of Acinetobacter oleivorans DR1 to determine strain-specific
genomic regions and gentisate biodegradation. Appl Environ Microbiol
77:7418–7424. http://dx.doi.org/10.1128/AEM.05231-11.
22. Kamolvit W, Higgins PG, Paterson DL, Seifert H. 2014. Multiplex PCR
to detect the genes encoding naturally occurring oxacillinases in Acineto-
bacter spp. J Antimicrob Chemother 69:959–963. http://dx.doi.org/10
.1093/jac/dkt480.
23. Peleg AY, Franklin C, Walters LJ, Bell JM, Spelman DW. 2006. OXA-58
and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter
junii blood culture isolate from Australia. Antimicrob Agents Chemother
50:399–400. http://dx.doi.org/10.1128/AAC.50.1.399-400.2006.
24. Partridge SR, Ginn AN, Paulsen IT, Iredell JR. 2012. pEl1573 Carrying
blaIMP-4, from Sydney, Australia, is closely related to other IncL/M plas-
mids. Antimicrob Agents Chemother 56:6029–6032. http://dx.doi.org/10
.1128/AAC.01189-12.
25. Sidjabat HE, Heney C, George NM, Nimmo GR, Paterson DL. 2014.
Interspecies transfer of blaIMP-4 in a patient with prolonged colonization
by IMP-4-producing Enterobacteriaceae. J Clin Microbiol 52:3816–3818.
http://dx.doi.org/10.1128/JCM.01491-14.
26. Huovinen P, Jacoby GA. 1991. Sequence of the PSE-1 beta-lactamase
gene. Antimicrob Agents Chemother 35:2428–2430. http://dx.doi.org/10
.1128/AAC.35.11.2428.
27. Higgins PG, Wisplinghoff H, Stefanik D, Seifert H. 2004. In vitro
activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and
tazobactam alone or in combination with beta-lactams against epidemio-
logically characterized multidrug-resistant Acinetobacter baumannii
strains. Antimicrob Agents Chemother 48:1586–1592. http://dx.doi.org
/10.1128/AAC.48.5.1586-1592.2004.
28. Chu YW, Afzal-Shah M, Houang ET, Palepou MI, Lyon DJ, Woodford
N, Livermore DM. 2001. IMP-4, a novel metallo-beta-lactamase from
nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and
1998. Antimicrob Agents Chemother 45:710–714. http://dx.doi.org/10
.1128/AAC.45.3.710-714.2001.
29. Huang LY, Lu PL, Chen TL, Chang FY, Fung CP, Siu LK. 2010.
Molecular characterization of beta-lactamase genes and their genetic
structures in Acinetobacter genospecies 3 isolates in Taiwan. Antimicrob
Agents Chemother 54:2699–2703. http://dx.doi.org/10.1128/AAC.01624
-09.
30. Kim CK, Lee Y, Lee H, Woo GJ, Song W, Kim MN, Lee WG, Jeong SH,
Lee K, Chong Y. 2010. Prevalence and diversity of carbapenemases
among imipenem-nonsusceptible Acinetobacter isolates in Korea: emer-
gence of a novel OXA-182. Diagn Microbiol Infect Dis 68:432–438. http:
//dx.doi.org/10.1016/j.diagmicrobio.2010.07.014.
31. Roca I, Mosqueda N, Altun B, Espinal P, Akova M, Vila J. 2014.
Molecular characterization of NDM-1-producing Acinetobacter pittii iso-
lated from Turkey in 2006. J Antimicrob Chemother 69:3437–3438. http:
//dx.doi.org/10.1093/jac/dku306.
32. Yang J, Chen Y, Jia X, Luo Y, Song Q, Zhao W, Wang Y, Liu H, Zheng
D, Xia Y, Yu R, Han X, Jiang G, Zhou Y, Zhou W, Hu X, Liang L, Han
L. 2012. Dissemination and characterization of NDM-1-producing Acin-
etobacter pittii in an intensive care unit in China. Clin Microbiol Infect
18:E506–E513. http://dx.doi.org/10.1111/1469-0691.12035.
33. Idzenga D, Schouten MA, van Zanten AR. 2006. Outbreak of Acineto-
bacter genomic species 3 in a Dutch intensive care unit. J Hosp Infect
63:485–487. http://dx.doi.org/10.1016/j.jhin.2006.03.014.
34. Schleicher X, Higgins PG, Wisplinghoff H, Korber-Irrgang B, Kresken
M, Seifert H. 2013. Molecular epidemiology of Acinetobacter baumannii
and Acinetobacter nosocomialis in Germany over a 5-year period (2005–
2009). Clin Microbiol Infect 19:737–742. http://dx.doi.org/10.1111/1469
-0691.12026.
Case Report
730 jcm.asm.org February 2015 Volume 53 Number 2Journal of Clinical Microbiology
 o
n
 M
ay 11, 2015 by UQ Library
http://jcm.asm.org/
D
ow
nloaded from
 
